Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2024 * | 59,96 Md 54,69 Md | CA 2025 * | 62,57 Md 57,07 Md | Capitalisation | 145 Md 132 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 6,75 Md 6,15 Md | Résultat net 2025 * | 9,29 Md 8,47 Md | VE / CA 2024 * | 3,21 x |
Dette nette 2024 * | 47,04 Md 42,91 Md | Dette nette 2025 * | 41,91 Md 38,23 Md | VE / CA 2025 * | 2,99 x |
PER 2024 * |
18,8
x | PER 2025 * |
13,7
x | Employés | - |
Rendement 2024 * |
6,61% | Rendement 2025 * |
6,78% | Flottant | 59,09% |
Dernier transcript sur Pfizer Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/01/93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 66 | 01/04/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/09/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,47% | 664 Md | |
+30,54% | 567 Md | |
-6,33% | 354 Md | |
+19,35% | 330 Md | |
+4,23% | 286 Md | |
+14,45% | 234 Md | |
+4,98% | 199 Md | |
-10,10% | 196 Md | |
-4,04% | 148 Md |
- Bourse
- Actions
- Action PFE
- Action